Blackrock Neurotech

In a significant step forward in medical science, researchers from Northwell Health’s Feinstein Institutes for Medical Research have successfully conducted the first double neural bypass operation - employing our Utah Array. Keith Thomas, a 45-year-old man paralyzed from the chest down due to a diving accident, is the first to experience the transformative results of this operation. The researchers successfully implanted our Utah Array into specific regions of Thomas's brain to stimulate motion and feeling. When Thomas visualizes a movement, our device captures the electrical signals in his brain and relays them to a computer that decodes the signals and stimulates the appropriate muscles, thus facilitating the movement Thomas imagines. The same process aids in restoring Thomas's sense of touch. Sensors on his skin send signals to the computer, which communicates with the Utah Arrays in his brain, enabling him to experience tactile sensations once again. Post-operation, Thomas has demonstrated significant progress, regaining the ability to move his arms and feel sensations on his skin. This operation marks a remarkable advancement in paralysis research and brain-computer interfacing, taking a giant leap forward in our understanding and ability to restore mobility and sensation in individuals affected by paralysis. Read the full TIME story and watch Keith's story here: https://lnkd.in/g9exCUhW #BCI #Neurotech #Medtech #Neuroscience #Technology #Paralysis #Braincomputerinterface

We are excited to announce our official collaboration with Noldus Information Technology, a global leader in behavioral research solutions trusted by over 60,000 researchers worldwide! This strategic partnership integrates our advanced neural recording systems with Noldus' EthoVision XT behavioral tracking capabilities, creating a seamless platform for neuroscience research. The integration enables real-time synchronization of behavioral data with high-resolution neural recordings in rodent studies, offering researchers profound insight into the relationship between neural activity and behavior. What this means for researchers: -Streamlined workflow with near plug-and-play setup -Precise correlation between neural signals and behavioral outcomes -Enhanced research efficiency through unified data collection -More comprehensive understanding of neurobehavioral dynamics Together, we're not just combining technologies – we're accelerating the future of neurotechnology to unlock deeper understanding of the brain, creating more powerful solutions for the scientific community. #Neurotechnology #Research #Behavior

Day 1 of Society for Neuroscience #SfN24 in Chicago! It was a thrilling day, especially as a research participant in the ReHAB study is onsite at our booth during certain exhibit hours. Yesterday, plenty of attendees got a chance to stop by and meet with the participant and the team. If you missed the opportunity, stop by Booth 1629 today from 1-2 central time or Tuesday 12:30 to 1:30. #clinicaltrials #neuromodulation #neurostimulation #spinalcordinjury Bill Memberg, Bolu Ajiboye, Emily Graczyk, Louis Stokes Cleveland Vamc Case Western Reserve University, University Hospitals, Blackrock Neurotech, Society for Neuroscience

Meeting with Blackrock Neurotech CEO, Marcus Gerhardt who is a pioneer in Brain Computer Interface already implanted BCi in 45 patients (way ahead of Elon Musk company) at the Society for Neuroscience. They will be one of our Keynotes at 22nd annual Society for Brain Mapping & Therapeutics (SBMT) (SBMT) in LA (Feb 27-March 2nd) at the LA convention center and also be nominated for Pioneer in Technology Development of World Brain Mapping Foundation

Ian Burkhart and I invite you to join us at our SfN2024 poster! We'll be at I39 on Tuesday morning with updated information (as of September 2024) from our recent publication https://lnkd.in/gMnF2_Vb

Join us today for two groundbreaking panel sessions at SfN2024 (booth #1429), exploring the frontiers of implantable brain-computer interface technology! 11AM-11:30AM: "Translational Neuroscience: Bridging Animal Studies and Neuroprosthetics" Melissa Franch, PhD, Postdoctoral Associate at Baylor College of Medicine, moderated by Nivas Asok Kumar, PhD, will take us on a fascinating journey from non-human primate research to human brain function studies. Discover how laboratory breakthroughs are shaping the future of neuroprosthetic devices! 1PM-2PM: "Real-World Experiences of BCI Pioneers" Moderated by Ian Burkhart, president of the North American Spinal Cord Injury Consortium and founder of the BCI Pioneers Coalition, this panel features BCI Pioneers Scott Imbrie and James Johnson sharing their transformative experiences. From regaining robotic arm control to exceeding expectations in daily life, these pioneers offer unique insights into living with cutting-edge neurotechnology. Don't miss this opportunity to gain valuable perspectives on the latest developments in BCI technology, its impact on daily life, and the crucial role of user experiences in advancing neuroscience. And of course, get your questions ready. See you soon! #SfN2024 #Neurotechnology #BCI #BrainComputerInterface

Join us today at 11AM (SfN booth #1429) for an illuminating discussion with BCI Pioneers Nathan Copeland and William Rinaldi, moderated by Dr. John Downey of the University of Chicago. Nathan, with the longest history of BCI implantation, and William, who transitioned to research participant after a life-altering accident, will share their unique perspectives on living with and advancing brain-computer interface technology. This panel offers rare, firsthand accounts of the unexpected challenges, discoveries, and personal growth experienced by those at the forefront of BCI usage. Dr. Downey will guide the conversation, providing context on cutting-edge intracortical BCI technology for robotic prosthetics. Attendees will gain valuable insights into the latest developments in BCI technology, its impact on daily life, and the crucial role of user perspectives in shaping the future of neurotechnology. See you soon! #SfN2024 #Neurotechnology #BCI

The Blackrock Neurotech team is headed to Chicago next week for #SfN2024 and we're excited. Mark your calendars and make sure to visit us at booth #1429. Our presence at SfN this year is particularly exciting as we bring our popular Ephys Lounge talks to the booth on Sunday and Monday. These sessions offer a unique opportunity to engage with BCI pioneers, including Ian Burkhart, Nathan Copeland, and some new faces. You'll also hear from brilliant researchers such as Melissa Franch, PhD and John Downey, among others, who are pushing the boundaries of what is possible in neurotechnology. We're looking forward to connecting with colleagues, sharing insights, and demonstrating how Blackrock Neurotech is empowering innovative research in the field. Whether you're a long-time collaborator or new to our work, we welcome you to stop by, explore our cutting-edge technology, and discuss the future of neuroscience and BCI applications. For more information about our presence at SfN, including a full schedule of our Ephys Lounge talks, please visit: https://lnkd.in/gwiW_xdf 🌬See you in Chicago! #Neuroscience #BCI #Neurotech #Innovation #SfN2024

We are thrilled to share a comprehensive review of implantable brain–computer interfaces (iBCIs) published in Nature Portfolio Reviews Bioengineering, authored by BCI pioneer Ian Burkhart and colleagues. This landmark paper highlights the incredible strides our field has made over the past 25 years—a journey we are proud to be a part of!   Key insights from the review:  -Global Collaboration: 21 research groups worldwide have worked with 67 participants to restore or rehabilitate motor, sensory, or speech functions using iBCIs.  -Advancement Priorities: Emphasizes the importance of improving participant diversity, fostering data sharing, and enhancing collaborative research to accelerate iBCI translation and commercialization.  -Increasing Longevity: Participation durations average over three years, with some extending beyond nine—showcasing the technology’s long-term viability and potential as a lifetime solution.  -Technological Advancements: Integration of machine learning and AI has dramatically improved decoding speed and accuracy, enabling more precise connections between the brain and external devices.    As for Blackrock Neurotech:   -Our NeuroPort microelectrode array has been used by 13 research groups and implanted in 38 of the 67 participants as of December 2023 and growing today, demonstrating the trust placed in our technology.  -Offering the highest spatial resolution among iBCI electrodes, the NeuroPort enables precise neuronal-level measurements—a critical factor in restoring motor control for those affected by spinal cord injuries, stroke, ALS, and other conditions.    Congratulations to Ian Burkhart, Michelle P., Jose L Contreras-Vidal, Ph.D.s, and all the researchers, participants, and collaborators who have contributed to this remarkable field. Together, we’re unlocking human potential by bridging the gap between the brain and technology, poised to lead the future of neurotechnology. 🔗 Read the full paper here:  https://lnkd.in/gwcSsC_T #BCI #Braincomputerinterface #Medtech #Neurotech

Happy to complete the Hands-On workshop hosted by Blackrock Neurotech team at their Salt Lake City, Utah campus! It was a great opportunity to gain valuable insights into their cutting-edge product development and explore future directions in the field of neurotechnology.